The study examined records for more than 124,000 people with type 2 diabetes over a 7-year period.
Having an annual flu vaccination is a public health staple, but new research shows it’s especially important for those with type 2 diabetes (T2D).
The seasonal influenza vaccine may sharply reduce both death rates and hospitalization among those with T2D, according to research from the Imperial College of London.
Eszter Vamos, MD, PhD, and co-authors examined 7 years of data from the Clinical Practice Research Datalink, involving 124,503 adults with T2D. After adjusting for the fact that those who got vaccines were older and had more comorbidities, they found that getting the vaccine was associated with lower administration rates for stroke, with an incidence rate ratio (IRR) of 0.77; for heart failure, with an IRR of 0.78; and pneumonia or influenza, with an IRR of 0.85.
Those who had the vaccine also had lower rates of all-cause mortality (IRR 0.76), and were less likely to be admitted for a heart attack the flu season (IRR 0.81).
“This study has shown that people with T2D may derive substantial benefits from current vaccines, including protection against hospital admission for some major cardiovascular outcomes,” the authors wrote. “These findings underline the importance of influenza vaccination as part of comprehensive secondary prevention in this high-risk population.”
The authors recommended efforts to boost vaccination rates in the T2D population.
Reference
Vamos EP, Page UJ, Curcin V, et al. Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes [published online July 25, 2016]. CMAJ. 2016; doi: 10.1503/cmaj.151059CMAJ
Exclusive Telemedicine Use Linked to Less Favorable Glycemic Outcomes for T2D Endocrinology Care
December 6th 2023Adults with type 2 diabetes (T2D) undergoing endocrinology care are more likely to experience less favorable hemoglobin A1c improvements if they only use telemedicine compared with patients using in-person care or a mix of both.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Study Reveals Factors That Further Increase Colorectal Cancer Risk for Adults With T2D
November 14th 2023The strongest associations between diabetes and colorectal cancer risk were observed in participants with a recent diabetes diagnosis and those who had not undergone recent colonoscopy, underscoring the significance of cancer screening.
Read More
Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes
April 22nd 2021The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
Listen